Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymus Neoplasms × Drug Therapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 70 Breast Neoplasms 30 Lung Neoplasms 22 Colorectal Neoplasms 22 Rectal Neoplasms 21 Neoplasms 18 Esophageal Squamous Cell Carcinoma 18 Neoplasm Metastasis 15 Head and Neck Neoplasms 15 Esophageal Neoplasms 15 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Small Cell Lung Carcinoma 12 Pancreatic Neoplasms 12 Triple Negative Breast Neoplasms 11 Ovarian Neoplasms 11 Carcinoma, Squamous Cell 10 Nasopharyngeal Carcinoma 9 Colonic Neoplasms 8 Recurrence 7 Prostatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Leukemia, Myeloid, Acute 7 Sarcoma 6 Melanoma 6 Lymphoma, Non-Hodgkin 6 Uterine Cervical Neoplasms 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5

Interventions

ribociclib 1 pembrolizumab 1 palbociclib 1 epacadostat 1 amrubicin 1 Sunitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06750952 2024-12-27

iTHYM

Sun Yat-sen University

Phase 2 Not yet recruiting

Recurrence, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡